established by Bayer AG Germany as the first subsidiary of multi-national Pharma Company in Iran in 1960 and was put into operation in 1962. Since then, expanding capacity and production condition and improvement programs were planned with long-term perspective. Investing in 64% of Farabi Pharmaceutical Company in Isfahan in 1993 was such a great success for us for improving of the financial situation of the company. The company was changed from private joint stock into public joint stock in 1994. Then Integrated Management System (IMS) based on ISO 9001, ISO 14001 and OHSAS 18001 was settled in the company. Using scientific research and appropriate technologies for producing medicines and considering important factors such as quality, safety and hygiene, environment, CGMP, GLP and productivity, medicines with the highest efficacy are provided to the society on time. Quality is the most important subject in every process in our company. In order to produce prime quality products with the highest level of efficacy, we obtain our raw materials from the most reliable producers and all procedures from granulation to packing and shrinking are managed according to the international standard FDA, WHO, BP, USP and EP. There are two important subjects for pharmaceutical's consumers and costumers: easy access and therapeutic effects. It is obvious that pharmaceutical production consumers can not wait. And this is our everyday concern. We have been trying to expand our presence in supplying patient's needs in Iran, Middle East and Asia Pacific successfully using our long experience and records in Iran's pharmaceutical industry. Nowadays, Pars Darou produces over 60 different products especially antibacterial, antivirus, antifungal and antidepressant under generic and brand names in various dosage and is known as one of the authentic pharmaceutical company in research, production and supplying pharmaceutical products among the pharmaceutical companies. Also, Pars Darou is known as the leading company in growth, development, evolution and innovation in pharmaceutical industry.
